Opendata, web and dolomites

UbiCODE SIGNED

European Research Training to Decipher The Ub Code : identification of potential biomarkers and drug targets

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 UbiCODE project word cloud

Explore the words cloud of the UbiCODE project. It provides you a very rough idea of what is the project "UbiCODE" about.

modified    cell    scientists    modify    neurodegeneration    sumo    collaborative    pathologies    interestingly    forming    proteins    family    understand    essential    laquo    pharmaceutical    discovery    ubicode    right    status    ubl    raquo    therapeutic    cancer    language    time    explore    chains    defects    ptms    area    technological    hold    landscape    interconnected    attractive    unknown    model    decrypt    universal    ubiquitin    industry    post    manner    modification    effort    phosphorylation    biochemical    molecular    interaction    clinical    stability    homeostatic    homeostasis    complexity    efforts    expanded    multiple    ptm    modifications    regulate    levels    regulation    translational    ub    localisation    multidisciplinary    chemical    enzymes    fundamental    members    heterologous    acetylation    molecules    protein    infections    efficient    intricate    organisms    equilibrium    pharmacological    compartment    unprecedented    nedd8    intervention    unsuspected    inflammation    ways    themselves    code    joint    deciphered    cellular    function    latest   

Project "UbiCODE" data sheet

The following table provides information about the project.

Coordinator
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS 

Organization address
address: RUE MICHEL ANGE 3
city: PARIS
postcode: 75794
website: www.cnrs.fr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 3˙407˙194 €
 EC max contribution 3˙407˙194 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2017
 Funding Scheme MSCA-ITN-ETN
 Starting year 2018
 Duration (year-month-day) from 2018-01-01   to  2021-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS FR (PARIS) coordinator 525˙751.00
2    UNIVERSITY OF DUNDEE UK (DUNDEE) participant 546˙575.00
3    ACADEMISCH ZIEKENHUIS LEIDEN NL (LEIDEN) participant 510˙748.00
4    NOVO NORDISK A/S DK (BAGSVAERD) participant 290˙081.00
5    THE UNIVERSITY OF LIVERPOOL UK (LIVERPOOL) participant 273˙287.00
6    FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH FONDATION CH (BASEL) participant 265˙226.00
7    INSTITUT FUR MOLEKULARE BIOLOGIE GGMBH DE (MAINZ) participant 249˙216.00
8    JOHANN WOLFGANG GOETHE-UNIVERSITATFRANKFURT AM MAIN DE (FRANKFURT AM MAIN) participant 249˙216.00
9    MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV DE (MUENCHEN) participant 249˙216.00
10    ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS ES (DERIO VIZCAYA) participant 247˙872.00
11    MEDICAL RESEARCH COUNCIL UK (SWINDON) participant 0.00
12    Basque Country University ES (Leioa) partner 0.00
13    Hybrigenics FR (PARIS) partner 0.00
14    Merck KGaA DE (DARMSTADT) partner 0.00
15    Nova Medical School PT (Lisboa) partner 0.00
16    Novartis CH (Basel) partner 0.00
17    The Naked Scientists Ltd UK (Cambridge) partner 0.00
18    UbiQ NL (AMSTERDAM) partner 0.00
19    Ubiquigent Ltd UK (Dundee) partner 0.00
20    YELLOW RESEARCH NL (AMSTERDAM) partner 0.00

Map

 Project objective

Essential role of protein modification by members of the Ubiquitin family: Post-translational modifications (PTM) by members of the Ubiquitin (Ub) family represent an efficient way to regulate protein function at several levels: to change their localisation, activity, their interaction with partner proteins or their stability at the right time and cellular compartment, according to the cell requirements. Defects in this homeostatic equilibrium result in pathologies such as cancer, neurodegeneration, inflammation or multiple infections. For this reason, this research area has become very attractive for fundamental scientists as well as for the pharmaceutical industry aiming to identify potential targets for therapeutic intervention. Ub family members hold a homeostatic equilibrium within the cell and are interconnected in various ways including the regulation of enzymes that control the modified status of target proteins. Interestingly, Ub and Ub-like (UbL) proteins can modify themselves, forming intricate and complex chains. This landscape has recently expanded with the discovery of the formation of heterologous chains among UbL molecules including SUMO or NEDD8 but also other PTMs such as phosphorylation or acetylation. This unsuspected complexity of what is now known as the «Ubiquitin Code», which is an unknown universal language that needs to be deciphered to understand protein homeostasis and its associated pathologies. To decrypt this complex code requires joint collaborative multidisciplinary efforts at all levels, including the use of distinct molecular systems and model organisms and the latest technological developments to explore chemical, biochemical, molecular, pharmacological and clinical aspects of protein modification by members of the Ub family. UbiCODE represents an unprecedented effort to understand this code in an integrated manner.

 Deliverables

List of deliverables.
Supervisory Board Other 2020-04-16 14:16:31
Outreach and research article publications, meetings, events Documents, reports 2020-04-16 14:16:26
UbiCODE website launched and updated and presence in social media Websites, patent fillings, videos etc. 2020-04-16 14:16:21

Take a look to the deliverables list in detail:  detailed list of UbiCODE deliverables.

 Publications

year authors and title journal last update
List of publications.
2020 Zuzanna Kozicka, Georg Petzold, Nicolas H. Thomä
Taking the Brakes Off Targeted Protein Degradation
published pages: 16-18, ISSN: 2451-9456, DOI: 10.1016/j.chembiol.2019.12.010
Cell Chemical Biology 27/1 2020-02-05
2020 David A. Pérez Berrocal, Katharina F. Witting, Huib Ovaa, Monique P. C. Mulder
Hybrid Chains: A Collaboration of Ubiquitin and Ubiquitin-Like Modifiers Introducing Cross-Functionality to the Ubiquitin Code
published pages: , ISSN: 2296-2646, DOI: 10.3389/fchem.2019.00931
Frontiers in Chemistry 7 2020-02-04

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "UBICODE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "UBICODE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

ARCH (2019)

AGE-RELATED CHANGES IN HEMATOPOIESIS

Read More  

PARACAT (2019)

Paramagnetic Species in Catalysis Research. A Unified Approach Towards Heterogeneous, Homogeneous and Enzyme Catalysis

Read More  

CHANGE (2019)

Cultural Heritage Analysis for New GEnerations

Read More